TABLE 2.
PAEs for eperezolid (PNU-100592), linezolid (PNU-100766), and vancomycin activities against selected pathogens
| Organism | Agent | PAE (h)a
|
|
|---|---|---|---|
| 1× MIC | 4× MIC | ||
| S. aureus R323 (methicillin resistant) | Eperezolid | 0.5 ± 0.1 | 0.9 ± 0.2 |
| Linezolid | 0.5 ± 0.2 | 0.6 ± 0.0 | |
| Vancomycin | 1.9 ± 0.0 | 2.9 ± 0.0 | |
| S. epidermidis R264 (methicillin susceptible) | Eperezolid | 0.2 ± 0.3 | 0.9 ± 0.2 |
| Linezolid | 0.3 ± 0.5 | 1.1 ± 0.9 | |
| Vancomycin | 0.0 ± 0.0 | 2.3 ± 0.2 | |
| E. faecalis R581 (vancomycin resistant) | Eperezolid | 0.1 ± 0.0 | 0.2 ± 0.0 |
| Linezolid | <0.1 ± 0.4 | 0.1 ± 0.0 | |
| Vancomycin | NDb | ND | |
| E. faecium R20 (vancomycin resistant) | Eperezolid | 0.7 ± 0.4 | 1.2 ± 0.6 |
| Linezolid | 0.8 ± 0.5 | 1.4 ± 0.3 | |
| Vancomycin | ND | ND | |
Results are means ± standard deviations for two PAE experiments.
ND, not done.